Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation

Simple item page
dc.contributor.authorAkpanova, D.
dc.contributor.authorBerkinbayev, S.
dc.contributor.authorOspanova, D.
dc.contributor.authorMusagaliyeva, A.
dc.date.accessioned2017-09-19T11:23:31Z
dc.date.available2017-09-19T11:23:31Z
dc.date.issued2017-09-15
dc.identifier.citationAkpanova, D. et al.(2017) Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation. National Laboratory Astana, Nazarbayev Universityru_RU
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2621
dc.language.isoenru_RU
dc.publisherNational Laboratory Astana, Nazarbayev Universityru_RU
dc.rightsOpen Access - the content is available to the general publicru_RU
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectatrial fibrillationru_RU
dc.subjectwarfarinru_RU
dc.subjectgene polymorphismru_RU
dc.titleImpact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillationru_RU
dc.typeAbstractru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
IMPACT OF CYP2C9 AND VKORC1 GENES.pdf
Size:
96.36 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Abstracts